The Lancet

Advancing precision medicine for acute respiratory distress syndrome

aCenter for Acute Respiratory Failure and Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons and New York-Presbyterian Hospital, New ...
IEEE

Detection and Classification of Sleep Apnea and Hypopnea Using PPG and SpO

Abstract: In this work, a detection and classification method for sleep apnea and hypopnea, using photopletysmography (PPG) and peripheral oxygen saturation (SpO 2) signals, is proposed. The detector ...
ahajournals.org

Efficacy and Safety of Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension and Comorbid Chronic Obstructive Pulmonary Disease

Balloon pulmonary angioplasty (BPA) is a promising treatment modality for nonoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, BPA for atypical CTEPH with concurrent chronic ...
IEEE

Noncontact Multispectral SpO2 Prediction Based on Deep Ratio-of-Ratio Refinement With Optimal Band Selection and Shading Bias Removal

Abstract: Noncontact prediction of peripheral oxygen saturation (SpO2) is necessary for monitoring vital signs of patients afflicted by infectious disease or sensitive to skin irritation. Recently, ...
Journal of Medical Internet Research

Impact of Skin Pigmentation on Pulse Oximetry Blood Oxygenation and Wearable Pulse Rate Accuracy: Systematic Review and Meta-Analysis

Conclusions: SpO2 and PR measurements may be inaccurate across all skin pigmentation groups, breaching U.S. Food and Drug Administration guidance and industry standard thresholds. Pulse oximeters ...
Journal of Medical Internet Research

Validation of the Withings ScanWatch as a Wrist-Worn Reflective Pulse Oximeter: Prospective Interventional Clinical Study

Currently, no mass-market wrist-worn SpO2 monitor meets the medical standards for pulse oximeters. Objective: The main objective of this monocentric and prospective clinical study with single-blind ...
wahanariau

ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA Device

SAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today ...